|

Predicting Risk Factors for Exacerbation of Chronic Obstructive Pulmonary Disease

RECRUITINGSponsored by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Actively Recruiting
SponsorXinhua Hospital, Shanghai Jiao Tong University School of Medicine
Started2017-12-10
Est. completion2027-12-30
Eligibility
Age40 Years+
Healthy vol.Accepted

Summary

Exacerbations of chronic obstructive pulmonary disease (COPD) are unfavourable events in the course of disease for most COPD patients. Published evidence indicates a significant impact of exacerbations, especially if frequent, on patients' health-related quality of life (HRQL), disease progression, mortality, health care utilisation and costs. However, the severity,evolution and outcome of an exacerbation may differ significantly between patients - some patients will recover completely in a short period of time while others may die. The identification of risk factors for an adverse outcome could help in distinguishing patients who require more intense management in order to prevent failures, achieve satisfactory recovery and reduce the negative clinical and socioeconomic impact of exacerbations.The pathogenesis of COPD is still unclear, so there is no specific treatment at present .COPD was considered to be the result of a combination of environmental and genetic factors. Genetic factors play an important role in the acute exacerbation of COPD.Therefore, it is an urgent need to explore the heterogeneity of COPD phenotype from the perspective of genes and to seek individualized prevention and treatment programs.This study is intended to provide a theoretical basis for the prevention, evaluation and development of individualized treatment plans for acute exacerbation of COPD, thereby improving the prognosis of the disease.

Eligibility

Age: 40 Years+Healthy volunteers accepted
Inclusion Criteria:

* Clinical diagnosis of Chronic obstructive pulmonary disease
* aged \>= 40 years

Exclusion Criteria:

* spirometry can not be completed because of various reasons
* asthma
* pulmonary embolism
* lung cancer
* sequelae of tuberculosis
* extensive bronchiectasis
* interstitial lung disease
* left cardiac insufficiency

Conditions2

COPDChronic Obstructive Pulmonary Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.